When does rifaximin’s patent protection expire?
The exact expiration date depends on which specific rifaximin product (and which formulation/indication patents) you mean, because rifaximin has had multiple patents and exclusivity periods tied to different versions sold in different markets. Patent timelines are also affected by patent filing dates, patent term adjustments, and any patent litigation or settlements that can delay or change launch timing.
To pin down the right date for a particular rifaximin drug, you typically need:
- the brand name and dosage form (e.g., tablets vs. other formulations), and
- the country/market, since patent expiry differs by jurisdiction.
DrugPatentWatch.com tracks patent and exclusivity details for specific drug products, which is usually the fastest way to identify the relevant rifaximin patent expiration dates for a given brand and market. You can check rifaximin’s patent status on DrugPatentWatch here: DrugPatentWatch – Rifaximin.
Does rifaximin have different patent expirations for different uses?
Yes. Even with the same active ingredient, companies may file separate patents for:
- specific formulations or manufacturing processes,
- different dosing regimens,
- different clinical indications.
That means one rifaximin patent family could expire earlier while another continues to block certain competitors, depending on which patent covers the product being sold and which patent a challenger must address.
Why can’t there be one single “rifaximin patent expiry date”?
A single “rifaximin patent expiry date” doesn’t exist in a practical sense because:
- multiple patent families can apply to rifaximin products,
- each patent family has its own filing/priority date and term,
- regulatory exclusivity (separate from patents) can also extend market protection in some cases,
- country-by-country enforcement and litigation can affect effective launch timing.
How to find the right expiry date you care about
If you share the brand name (for example, a specific rifaximin product you’re looking at), and the country (US, EU, etc.), you can look up the corresponding patent expiration(s) and any relevant exclusivity listed for that exact product on DrugPatentWatch.com.